![bpc-157 clinical trial multiple sclerosis Rising Use of Unapproved (“Wolverine Peptide”) and Associated Patient-Reported Outcomes Curated from Notes[v1] 2026-08-28](https://www.preprints.org/frontend/picture/ms_xml/manuscript/b37b25b53488d669b4ff289e54ab3dda/preprints-231909-g002.png)
bpc-157 clinical trial multiple sclerosis
Shipping Estimate
bpc-157 clinical trial multiple sclerosis Rising Use of Unapproved (“Wolverine Peptide”) and Associated Patient-Reported Outcomes Curated from Notes[v1] 2026-08-28
USD25.40
USD50.40
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22